Samil Pharmaceutical Non-Registered Director Han Byeong-ik Acquires 1,000 Shares via Open Market Purchase…Slight Decrease in Ownership Percentage
Samil Pharmaceutical non-registered director Han Byeong-ik purchased 1,000 common shares on June 1, 2026 at 7,340 KRW per share through open market transaction. His total holdings increased from 6,058 to 7,058 shares, but the ownership percentage edged down from 0.04% to 0.03% due to an increase in total outstanding shares.
Insider buying typically signals management's confidence that the stock is undervalued. However, the purchase amount is only about 7.34 million KRW, limiting its direct impact on the stock price.
[AI Summary]The insider's minor share purchase reflects positive internal sentiment, but given the negligible size relative to market cap, its effect is likely confined to providing a favorable psychological cue rather than driving a material price rally.
KOSPI Filing Information
Filing: Report on Ownership of Specific Securities by Executives and Major Shareholders